Identifying and recruiting healthy control subjects from a managed care organization: A methodology for molecular epidemiological case-control studies of cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 8, 1997, Pages 565-571

  Hudmon, Karen Suchanek ^a   Honn, Susan E ^a   Jiang, Hong ^a   Chamberlain, Robert M ^a   Xiang, Wenguang ^a   Ferry, George ^b   Gosbee, Wayne ^b   Hong, Waun Ki ^a   Spitz, Margaret R ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b Kelsey Seybold Research Foundation   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; ETHNIC GROUP; HEALTH MAINTENANCE ORGANIZATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DISEASE SUSCEPTIBILITY; EPIDEMIOLOGY, MOLECULAR; FEASIBILITY STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATIENT SELECTION; RISK FACTORS; SMOKING; TEXAS; URBAN POPULATION;

EID: 0030837744     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Spitz, M. R., Hsu, T. C., Wu, X. F., Fueger, J. J., Amos, C. I., and Roth, J. A. Mutagen sensitivity as a biologic marker of lung cancer risk in African Americans. Cancer Epidemiol., Biomarkers & Prev., 4: 99-103, 1995.
2. Wacholder, S., McLaughlin, J. K., Silverman, D. T., and Mandel, J. S. Selection of controls in case-control studies. I. Principles. Am. J. Epidemiol., 135: 1019-1028, 1992.
3. Wacholder, S., Silverman, D. T., McLaughlin, J. K., and Mandel, J. S. Selection of controls in case-control studies. II. Types of controls. Am. J. Epidemiol., 135: 1029-1041, 1992.
4. Wacholder, S., Silverman, D. T., McLaughlin, J. K., and Mandel, J. S. Selection of controls in case-control studies. III. Design options. Am. J. Epidemiol., 135: 1042-1050, 1992.
5. R for Windows™ Advanced Statistics, Release 6.1, Chicago, IL, 1994.
6. Johnson, R. A., and Murata, P. J. Demographic, clinical, and financial factors relating to the completion rate of screening mammography. Cancer Detect. Prev., 11: 259-266, 1988.
7. Evans, A. M., Love, R. R., Meyerowitz, B. E., Leventhal, H., and Nerenz, D. R. Factors associated with active participation in a cancer prevention clinic. Prev. Med., 14: 358-371, 1985.
8. Rutledge, D. N., Hartmann, W. H., Kinman, P. O., and Winfield, A. C. Exploration of factors affecting mammography behaviors. Prev. Med., 17: 412-422, 1988.
9. Sandler, R. S., DeVellis, B. M., Blalock, S., and Holland, K. L. Participation of high-risk subjects in colon cancer screening. Cancer (Phila.), 63: 2211-2215, 1989.
10. Yeomans-Kinney, A., Vernon, S. W., Frankowski, R. F., Weber, D. M., Bitsura, J. M., and Vogel, V. G. Factors related to enrollment in the breast cancer prevention trial at a comprehensive cancer center during the first year of recruitment. Cancer (Phila.), 76: 46-56, 1995.
11. Halabi, S., Vogel, V. G., Bondy, M. L., and Vernon, S. W. Recruiting older women for screening mammography. Cancer Detect. Prev., 17: 359-365, 1993.
12. Roetzheim, R. G., Van Durme, D. J., Brownlee, H. J., Herold, A. H., Woodard, L. J., and Blair, C. Barriers to screening among participants of a medi-promoted breast cancer screening project. Cancer Detect. Prev., 17: 367-377, 1993.
13. Lerman, C., Rimer, B. K., Trock, B., Balshem, A., and Engstrom, P. F. Factors associated with repeated adherence to breast cancer screening. Prev. Med., 19: 279-290, 1990.
14. Fletcher, S. W., Morgan, T. M., O'Malley, M. S., Earp, J. L., and Degnan, D. Is breast self-examination predicted by knowledge, attitudes, beliefs, or sociodemographic characteristics? Am. J. Prev. Med., 5: 207-215, 1989.
15. Zapka, J. G., Stoddard, A. M., Costanza, M. E., and Greene, H. L. Breast cancer screening by mammography: utilization and associated factors. Am. J. Public Health, 79: 1499-1502, 1989.
16. Fajardo, L. L., Saint-Germain, M., Meakem, T. J., Rose, C., and Hillman, B. J. Factors influencing women to undergo screening mammography. Radiology, 184: 59-63, 1992.
17. Champion, V. L. Compliance with guidelines for mammography screening. Cancer Detect. Prev., 16: 253-258, 1992.
18. Calnan, M. The health belief model and participation in programmes for the early detection of breast cancer: a comparative analysis. Soc. Sci. Med., 19: 823-830, 1984.
19. Rimer, B. K., Trock, B., Engstrom, P. F., Lerman, C., and King, E. Why do some women get regular mammograms? Am. J. Prev. Med., 7: 69-74, 1991.
20. Rimer, B. K., Davis, S. W., Engstrom, P. F., Myers, R. E., and Rosan, J. R. Some reasons for compliance and noncompliance in a health maintenance organization breast cancer screening program. J. Compl. Health Care, 3: 103-114, 1988.
21. Sutherland, H. J., Carlin, K., Harper, W., Martin, L. J., Greenberg, C. V., Till, J. E., and Boyd, N. F. A study of diet and breast cancer prevention in Canada: why healthy women participate in controlled trials. Cancer Causes & Control, 4: 521-528, 1993.
22. Mettlin, C., Cummings, K. M., and Walsh, D. Risk factor and behavioral correlates of willingness to participate in cancer prevention trials. Nutr. Cancer, 7: 189-198, 1985.
23. Miller, H. H., Bauman, L. J., Friedman, D. R., and DeCosse, J. J. Psychosocial adjustment of familial polyposis patients and participation in a chemoprevention trial. Int. J. Psychiatry Med., 16: 211-230, 1986.
24. Lerman, C., Rimer, B. K., Daly, M., Lustbader, E., Sands, C., Balshem, A., Masny, A., and Engstrom, P. F. Recruiting high risk women into a breast cancer health promotion trial. Cancer Epidemiol., Biomarkers & Prev., 3: 271-276, 1994.
25. Hudmon, K. S., and Kinney, A. Y. Issues of enrollment bias in cancer chemoprevention trials. Cancer Bull. (Houst.), 47: 339-342, 1995.
26. Hudmon, K. S., Chamberlain, R. M., and Frankowski, R. F. Outcomes of a placebo run-in period in a head and neck cancer chemoprevention trial. Controlled Clin. Trials, 18: 228-240, 1997.